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3. Introduction 
 
Harm reduction is at the heart of the Welsh Government’s Substance Misuse Strategy and 
reducing the number of drug-related deaths is a key aim (Welsh Government 2008). A large 
proportion of drug-related deaths are the result of accidental opiate overdose (European 
Drug Report 2016) and reducing the number of fatal (and non-fatal) poisonings is 
understandably a key target listed in the Substance Misuse Delivery Plan 2016-2018 (Welsh 
Government 2016a).   
 
In 2014, research was undertaken on a national scale to estimate the extent of non-fatal 
overdose among opioid users in Wales (Bennett, Holloway and Bird 2014). The research 
involved surveying all needle and syringe programme (NSP) users over a one-month period 
and asking them about their overdose experiences. Nearly half of all respondents (48%) 
reported having overdosed at some point in their lives and 15% said that they had done so 
in the last year. As part of this study, qualitative (telephone) interviews were undertaken 
with a small number of needle exchange users who had provided their phone numbers 
(confidentially) after completing the survey. These interviews highlighted some important 
issues that we felt needed to be investigated in more depth with a larger number of 
participants to achieve saturation of the issues. It was felt that more in-depth research 
would enable us to investigate more thoroughly the circumstances of overdose events 
(experienced or witnessed) and identify ways of reducing harm and ultimately saving lives.   
 
Funding was therefore sought from a Research Institute at the University of South Wales 
and matched with support from Welsh Government (in the form of the research time of Dr 
Rhian Hills) to undertake a large qualitative study of recent overdose events. The principal 
objectives of the study were to identify the factors that precipitate an overdose and to 
understand the short and long-term impact of such events on users and witnesses. The 
secondary objectives were to investigate the use of Take Home Naloxone and other harm 
reduction measures (e.g. CPR, ringing 999, using the recovery position) employed during 
overdose events. The third objective was to provide Welsh Government with a report based 
on the research findings that would help inform future policy and practice in relation to 
drug-related deaths.  This document is that report.  
 
While our study examined a large number of topics, this report focuses largely, but not 
exclusively, on one key issue, namely, overdose management (i.e. how people respond to 
overdose events)1.  The report begins by examining patterns in drug-related deaths on a 
global, European and UK basis to help put the research in context. It then examines the 
academic literature to establish what is currently known about the topic of overdose 
management. The report then provides an overview of the methods used and details of our 
sample of interviewees.  The main body of the report, where we present our findings, is 
divided into four sections, each focusing on a key issue identified in our analysis. Quotations 
from our interviewees are weaved into our discussions and provide evidence for the points 
being made. At the end of the report we consider the implications of the findings for policy 
and practice and we make some tentative recommendations for the future.  
 
                                                             
1 It is anticipated that subsequent reports will focus on other issues including overdose prevention. 
 5 
 
4. Prevalence of drug-related deaths 
 
In this section we examine the prevalence of drug-related deaths across the world to help 
put the current research into context.  We begin with a review of global rates and move on 
to consider rates in Europe. Finally, we examine data relating to the UK focusing on the 
prevalence of drug-related deaths in Wales. The broad goal of this review is to examine the 
extent of the problem and consider how the situation in Wales compares with elsewhere.  
 
Global rates 
 
Drug-related deaths are of international concern and data on the prevalence of drug-related 
deaths in multiple countries are published by the UNODC annually in the World Drug 
Report. The most recent report (published in 2016) estimates that in 2014 there were 
207,400 drug-related deaths corresponding to 43.5 deaths per million people aged 15 to 64. 
The estimated number of drug-related deaths reported by individual countries varies 
considerably by region2 ranging from a high of 85,900 in Asia3 to a low of 2,500 in Oceania 
(see Figure below extracted from the World Drug Report 2016). However, while Oceania 
reported the lowest total number of reported deaths this region was estimated to have the 
second highest rate per million population (101.5) second only to North America’s rate of 
164.5 per million population. Interestingly, Western and Central Europe were estimated to 
have the second lowest rate per million population (28.9) but the third highest total number 
of drug-related deaths (9,200).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                             
2 Methodological and reporting issues are recognised as potential confounding factors.  
3 In 2015 China gave its first-ever assessment of the human impact of drug overdose, saying there were as many as 49,000 
deaths in 2014. Source: Business Insider, June 24, 2015. http://www.businessinsider.com/r-china-says-economic-losses-
from-drug-abuse-hit-81-billion-a-year-2015-6?IR=T 
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Overdose deaths are reported to contribute to between roughly one-third and one-half of 
all these deaths and most are attributable to opioids (World Drug Report 2016). Based on 
these estimates, there were somewhere between 2,760 and 4,600 overdose deaths in 
Western and Central Europe in 2014. 
 
European rates 
 
Data on the prevalence of drug-related deaths in Europe are published annually by the 
European Monitoring Centre for Drugs and Drug Addiction. The most recent report 
(published in 2016) estimates that more than 70,000 lives were lost to drug overdoses in the 
EU in the first decade of the 21st Century (European Drug Report 2016). Between 2013 and 
2014, the number of overdoses in Europe increased by 11% to 6,800 from an estimated 
6,100 in 2013 (European Drug Report 2015, 2016). The proportion of overdose deaths 
involving opioids also increased during this period from 66% to 82% (a 24% increase). 
Overall, the rate of overdose deaths in Europe is estimated to be 18.3 per million population 
aged 15-64.  However, rates of over 40 deaths per million were reported in eight countries 
including the UK, which alone accounted for more than one-third (36%) of all overdose 
deaths in Europe4 (see Figure below extracted from the European Drug Report 2016).  
 
 
 
  
                                                             
4 National mortality rates vary considerably and are influenced by factors such as prevalence and patterns of drug use and 
methodological issues such as under-reporting and coding practices 
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England and Wales rates 
 
Annual data on the prevalence and characteristics of drug-related deaths in England and 
Wales are published annually by the Office of National Statistics (ONS). The figures 
presented in the statistical bulletins cover both deaths due to drug poisoning and deaths 
due to drug misuse. Deaths due to drug misuse are defined by ONS as: 
 
Either (a) a death where the underlying cause is drug abuse or drug dependence or 
(b) a death where the underlying cause is drug poisoning and where any of the 
substances controlled under the Misuse of Drugs Act 1971 are involved.  
(ONS 2016, p.4) 
 
In 2015 a total of 2,479 drug misuse deaths were registered in England and Wales, which is 
the highest number since records began and a 10% increase from the previous year (ONS 
2016). In Wales, while the numbers are small in comparison with those in England (168 
compared with 2,300), the proportional increase from 2014 was much higher (49% 
compared with 8%). The recent increase in Wales reversed a five-year downward trend and 
the number of registered deaths (168) and rate of registered deaths (58.3 per million 
population) is now the highest level since comparable records began in 19935.  
 
 
 2011 2012 2013 2014 2015 
Drug poisoning 215 214 208 168 238 
Drug misuse 148 135 135 113 168 
 
 
In line with global and European data, there has been a gradual increase in the number of 
drug misuse deaths involving heroin/morphine in England and Wales. In 2015 the number of 
deaths in Wales that involved heroin/morphine increased to 85, an increase of 93% from 
the 44 registered in the previous year (ONS 2016). Over time, there has also been a gradual 
increase in the number of drug misuse deaths resulting from accidental overdose in Wales. 
In 2015, 85% of drug misuse deaths were the result of accidental poisoning compared with 
74% in 2011.  
 
In summary, measuring drug-related deaths is methodologically tricky and notes to this 
effect are routinely included in the official reports cited above.  However, these reports are 
the best estimates available and while there are variations in methodology there is a general 
consensus that drug misuse deaths (of which a large proportion are accidental overdose 
involving heroin/morphine) are increasing in most countries including Wales.  The challenge 
now is to find ways of reversing this trend. One way in which many countries have 
endeavoured to do this has been through Take Home Naloxone programmes.  
 
 
                                                             
5 It is important to note that when the data are analysed by the year the death occurred rather than the year of 
registration, there is a much smoother trend in deaths related to drug misuse in Wales. This suggests that the large 
increase in the mortality rate in 2015 is likely an artefact of registration delays and the rate for deaths registered in 2014 
was artificially low. 
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5. Take Home Naloxone 
 
Opioid overdoses can often be prevented if substances such as naloxone are available 
(World Drug Report 2016). Naloxone is a drug that temporarily reverses the effects of an 
opiate overdose. More specifically, naloxone is an opioid antagonist, which blocks the 
actions of opioid medicines such as morphine, diamorphine, codeine, pethidine and 
methadone. Naloxone has a long history of use in the emergency treatment of opioid 
overdose (Maxwell et al. 2006). It counteracts the depressive respiratory effects of opioids 
and can bring an overdose patient back to consciousness in minutes following its 
administration.  
 
Take Home Naloxone (THN) schemes in which people at risk of opiate overdose are 
provided with ‘take home’ kits of naloxone for use in emergency overdose situations, have 
been operating around the world for several decades (Bennett and Holloway 2011).  For 
example, naloxone has been available over-the-counter in Italy since the 1980s and it has 
been used to counteract opiate overdose in the US for more than 20 years. Wales has been 
operating a THN scheme in Wales since 2009 and in 2011, after a pilot ‘demonstration’ 
period, the THN programme was rolled out across the country making it the first in the UK 
to launch a national THN scheme (McDonald et al 2016).   
 
Each year, Public Health Wales publishes a report on the distribution and use of naloxone 
across Wales (Public Health Wales 2016).  Since the THN scheme was first introduced in 
2009, more than 10,000 kits have been issued to nearly 6,000 unique individuals.  This 
includes 5,918 kits to new individuals and 4,634 kits as re-supply following the use, loss or 
expiry of previous kits. In 2015-16, 3,186 kits were issued (supplied and re-supplied), 
representing an increase of more than 14 per cent from the previous year.  In the last year, 
1,058 new individuals were supplied with THN and 937 existing service users were re-
supplied.  Use of THN was reported once for every nine individuals registered as a carrier of 
THN.  
 
Since 2009, THN has reportedly been used during 1,065 drug poisoning events including 433 
events during 2015-16. In relation to the latter, the outcome was reported for 392 events 
and fatalities occurred in less than one per cent of cases. In 85 per cent of cases THN was 
administered to a third party rather than to the owner of the kit, and 60 per cent of all 
reported drug poisoning events occurred within a private residence. Follow-on care (i.e. an 
ambulance) was requested and provided in 63 per cent of all cases where THN was used in a 
drug poisoning event, representing a 5.4 percentage point increase on the previous year. As 
with previous years the demographic profile of those individuals who had used THN 
included; living in non-secure accommodation, poly-drug use, and having experienced at 
least one previous non-fatal drug poisoning. 
 
While real progress has been made in disseminating THN kits across Wales (to 4,851 unique 
individuals), there is much more to be done. Indeed, recent estimates suggest that there are 
25,767 opioid users in Wales, which means that the vast majority of people potentially at 
risk of opioid overdose have not yet got kits. The challenge of distributing THN to those at 
risk of overdose is well documented.  In recognition of the difficulty and the need to make 
THN more widely available, the UK government changed the legislation in October 2015. 
The new law now permits drug workers employed through Local Authorities to distribute 
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THN kits to anyone with a need for naloxone.  Previously, it could only be issued on 
prescription by medical professionals to people at risk of an opioid overdose. The new 
legislation was accompanied by clinical guidance which stipulated that THN kits should be 
issued along with ‘suitable advice’. Precisely what ‘suitable advice’ means is not stated.  
 
Advice on how best to respond to and manage an overdose is routinely provided as part of 
the THN scheme. The training is often done in a group setting although one-to-one sessions 
have become increasingly popular in Wales. The sessions usually involve people being 
trained to recognise the signs and symptoms of an overdose and how best to respond and 
manage overdose events. The sessions often include guidance on the importance of calling 
999, placing someone in the recovery position, administering CPR and training on how to 
administer naloxone. The content of THN training sessions used to be guided by Welsh 
Government. However, following an evaluation of the scheme it was recommended that the 
training be shortened. The content of training sessions was subsequently left to the 
discretion of those distributing THN kits.   
 
The recent change in legislation means that THN can now be distributed more widely than 
before. This brings with it an opportunity to educate many more people about how to 
respond to and manage overdose events. It is therefore important to ensure that the 
education provided is appropriate, up-to-date and evidence-based. In the next section we 
review the evidence and examine what is currently known about the best way of responding 
to an overdose in order to save lives.  
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6. Literature review 
 
A rapid evidence review was undertaken to identify publications reporting findings from 
qualitative research on opiate overdose. To this end, searches were undertaken of four 
bibliographic databases (see Table 1). The search term used for the database searches was: 
‘qualitative AND overdose AND heroin’ in the abstract6.  The searches generated 111 hits 
relating to 62 unique studies. The titles and abstracts of these studies were reviewed and 
the full publications were obtained when they appeared to match our research interest. The 
papers from the database search and the references from the published papers were then 
read and those that met our selection criteria were included in the review. To be selected, 
the study had to present the results of a qualitative study that investigated overdose 
experiences (either witnessed or experienced) by drug users and the paper had to be 
published in the English language. In total, 53 studies met these criteria.  The most relevant 
of these papers are reviewed briefly in the paragraphs below7.   
 
Table 1 Results of literature searches 
 
Database Total ‘hits’ 
Web of Science 60 
ASSIA 9 
PsycINFO 17 
PubMed8 25 
TOTAL HITS 111 
  
TOTAL unique  62 
  
TOTAL relevant 53 
 
 
UK studies 
 
While most of the studies were based on research conducted outside of the UK, our review 
identified a small body of work based on research undertaken in the UK.  Interestingly, the 
most recently published UK paper was based on data collected from a study undertaken 
approximately 20 years ago (between 1997 and 1999) that examined iatrogenic harm after 
emergency treatment of heroin/opioid overdose (Neale and Strang 2015). The research was 
based on the re-analysis of: 70 face-to-face interviews conducted within a few hours of an 
overdose occurring, observations within hospital settings and a further 130 interviews with 
illicit opiate users. The researchers found that users’ views did not always correspond with 
the observation of events.  While users repeatedly reported harm caused by naloxone over-
antagonism (e.g. acute withdrawal symptoms) the observational data indicated that 
participants did not always know that they had been given naloxone and doctors did not 
                                                             
6
 Typically, abstracts are 250 words long while titles are usually less than 20 words.  Searching abstracts for key terms is 
therefore likely to generate more relevant hits than a search of titles.    
7 An in-depth review of all 53 papers is beyond the remit of this report. We have therefore focused our attention on the 
papers that are most relevant to the current report, i.e. on overdose management.  
8 PubMed comprises more than 26 million citations for biomedical literature from MEDLINE, life science journals, and 
online books. 
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necessarily admit it incautiously. The authors refer to the concept of contemporary legend 
to help explain their findings.  They assert that ‘the power of belief and folklore over lived 
experience [reminds] us that instances of negative events (however rare or unlikely) can 
have a disproportionately harmful impact when they do occur’ (p. 6). Through 
contemporary legend, the authors found that naloxone was transformed from a life-saving 
medication into a painful punishment administered by a hostile workforce. To address this 
problem, the authors recommend that workers need to apply ‘good treatment’ that builds 
trust with patients, is sensitive to concerns and provides clear information.  More attention 
to titrating the most appropriate dose is also recommended in order to minimise the risk of 
naloxone-precipitating withdrawal.   
 
Rome and Boyle (2008) conducted a comprehensive study funded by the Scottish 
Government, which included a thorough review of the literature as well as qualitative and 
quantitative research on overdose. The qualitative element of the research involved in-
depth interviews with 58 drug users who had either experienced or witnessed an overdose 
and with 10 family members. The study was driven by two aims: to investigate how to 
increase the number of witnesses to drug overdose calling for help quickly; and to 
investigate what measures could be effective in preventing death from overdose while help 
is on its way.   
 
Among the respondents who had witnessed an overdose, just over half (56%) intervened as 
soon as they realised someone had overdosed. A range of resuscitation methods were 
employed including use of appropriate actions (e.g. CPR, mouth-to-mouth, recovery 
position) and inappropriate actions (e.g. slapping, walking the person about, cold water).  In 
a small number of cases, the overdose victim was placed outside (9%) alone. Nearly two-
thirds of witnesses (61%) reported calling an ambulance at their last witnessed overdose 
and in nearly half of these cases the ambulance was called immediately or within five 
minutes. Barriers to calling 999 were most commonly found to be presence of the police 
and legal repercussions. Other barriers were also reported and these included fearing 
repercussions from the victim’s family members, friends or others, or more pragmatic 
reasons such as the time it takes to clean up any evidence of drug taking, or lack of 
knowledge about appropriate responses.  
 
The report included a list of recommendations. In relation to overdose management, Rome 
and Boyle (2008) recommended that (a) action be taken at national and local level to ensure 
that information about management (and prevention) of overdose is available to drug users 
and their families, and (b) that information on current policy on police attendance at 
overdose events and the positive benefits that this brings must also be made available to 
drug users and their families.  
 
Wright et al (2006) conducted in-depth face-to-face interviews with 27 people with a history 
of heroin use and homelessness who had experienced or witnessed a heroin overdose. The 
research found that homeless people were able to recognise signs of a heroin overdose and 
many were prepared to take responsibility and be proactive in taking measures to revive 
and resuscitate a fellow user in an overdose situation. Sometimes the actions taken were 
appropriate (e.g. use of CPR) but other less appropriate methods were also used (e.g. 
walking the victim around and inflicting pain by slapping).  Willingness to take responsibility 
was found to be context dependent.  Reluctance was more common if responding involved 
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calling the police or if an overdose occurred in a hostel setting (which might result in 
eviction and loss of tenancy).  Lack of knowledge regarding how to act in an overdose 
situation also prevented some people from taking responsibility during an event. With 
regard to naloxone, the research found that many users had good prior knowledge which 
demonstrated that any future9 programme of THN would ‘not be entirely alien to homeless 
drug users’ (p. 4).  They also found that abuse of naloxone was rare and that the over-riding 
theme was of reluctance to use it rather than to abuse it. While there were some who 
believed that naloxone might be used maliciously to induce withdrawal, such beliefs were 
not grounded in previous experience.  The authors concluded that a programme of peer use 
THN among homeless drug users could be feasible so long as prior training is provided.  
 
Finally, Beswick et al (2002) examined accuracy and myths in peer resuscitation methods for 
opiate overdose among 108 opiate users in London, UK. The participants in this study 
reported a wide range of responses to overdose events.  These included ‘probably valuable’ 
responses (including putting the victim in the recovery position, calling 999 and using 
naloxone) but also ‘ineffective or frankly harmful’ responses (including injecting with salt 
solution and immersing in a cold bath) (p. 1108). The participants were asked about their 
experiences of witnessing fatal overdoses and some reported that little action was taken 
during the events.  In one case this was because the victim was asleep in another room but 
in others it was because the witness did not know what to do, although they did know to 
call an ambulance but then left the victim, who later died, alone. The authors concluded 
that there was a need for inpatient overdose prevention programmes and that 
enhancements in both confidence and knowledge of effective action could help to save 
lives.  
 
 
United States 
 
Outside of the UK research on overdose management has been more prevalent.  In the US, 
for example, our review identified several studies that had used qualitative methods to 
investigate the issue. Wagner et al (2014), for example, investigated the experience of 
responding to drug overdose among individuals trained in overdose prevention in Los 
Angeles, California.  These authors highlighted the effects that responding to overdoses had 
for ‘responders’. Positive effects included an increase in self confidence and control, feelings 
of pride and heroism as well as a recognition of one’s own expertise.  Negative effects 
included a sense of burden, anger, fear and regret, which occasionally resulted in the 
severing of social ties.  The authors concluded that taking up the role of responder can 
involve taking up a new social role that has positive effects but that it also can result in 
some stress that may require additional support.  Furthermore, equipping people with the 
skills, technology and support needed to respond to an overdose ‘has the potential to 
confer both individual and community-wide benefits’ (p. 157).  
 
Frank et al (2014) conducted semi-structured interviews with 46 prescription opioid users 
aged 18-32 in New York City to investigate overdose experiences and knowledge.  The 
researchers found that participants were relatively uninformed about overdose awareness, 
avoidance and response strategies including naloxone. This was despite significant 
                                                             
9
 This study was published in 2008 several years before national roll-out of THN programmes in Wales and Scotland.  There 
is no national programme currently operating in England although THN is distributed in some areas.   
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experience of overdose events, which included overdose deaths. The researchers reported 
that participants viewed themselves as distinct from traditional heroin users and as such 
were unlikely to use the harm reduction services (e.g. NSPs) where messages about 
overdose prevention and response are often provided.  The authors conclude that there is a 
need to develop ‘innovative outreach strategies’ to better reach and serve young 
prescription opioid users.  The authors also recommend that prevention efforts, including 
reversal education, be specifically tailored for and targeted to this vulnerable group. 
 
Sherman et al (2009) conducted in-depth interviews with 25 participants of the Staying Alive 
programme in Baltimore, US to investigate diffusion of overdose prevention information 
among drug users.  The study found that participants shared what they had learned in both 
their actions and conversations both within and outside of overdose events. Interestingly, 
talking about and teaching others how to use naloxone ‘was central to most overdose 
prevention conversations’ (p. 141)  However, participants reported the difficulty they had in 
talking to their friends directly about overdose prevention, and there were limited examples 
of this kind of discussion.  The authors suggested that overdose prevention training could be 
enhanced if it included brief communications skills training with the aim of increasing 
‘overdose prevention talk’ in combination with information about naloxone. In conclusion, 
the authors reported that injecting drug users are both interested in and able to diffuse 
overdose prevention and response skills to their networks.  The importance of promoting 
the diffusion of such information and skills was also recognised.  
 
Sherman et al (2008) conducted qualitative interviews with 31 injecting drug users and 
explored responses to witnessed overdose events when naloxone was used and events 
where it was not.  Participants reported that they considered a range of factors when 
deciding how to respond. Fear of legal consequences was prevalent but this was 
‘counterbalanced’ by the wish to save a life (p. 3).  A range of responses (appropriate and 
inappropriate) were reported including: calling for an ambulance, use of naloxone, use of 
cold water or ice, hitting the victim, sternum rubbing, and mouth-to-mouth resuscitation.  
Interestingly, the authors described that inappropriate responses (e.g. slapping, use of 
water/ice, etc) were rarely reported and they predicted that use of such methods would 
‘hopefully diminish over time’ (p. 4). The research identified a desire and ability to help 
among drug-using peers and participants were proud that they were able to intervene and 
save a life.  The main conclusion drawn was that teaching IDUs how to use naloxone is an 
effective risk reduction strategy. 
 
 
Other countries 
 
Research on overdose events has also been conducted in countries other than the UK and 
the US.  Bartlett et al (2011), for example, conducted a qualitative evaluation of a peer-
implemented overdose response pilot project in Gejiu, China. This study explored local 
understandings of risk factors related to overdose and assessed barriers to overdose 
response. The research identified a general reluctance to call for emergency rescue.  
Barriers to ringing for help included privacy concerns and the potential impact on family 
relationships.  Concerns were also expressed over the potential of the police attending the 
scene and fear of urine tests that could result in up to three years of detention in 
compulsory detoxification centres.  Others opted out of calling for emergency help because 
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they had faced discrimination in hospitals where no concern was shown for them and where 
some professionals refused to help. Interestingly, virtually all of the participants reported 
that the cost, which included ambulance transportation, naloxone administration, and a 
medical check-up at the hospital, was a ‘serious barrier to treatment’ (p. 303).  The authors 
concluded by describing that they would explore strategies, including targeted trainings and 
new partnerships with local hospitals, to try and reduce opiate overdose mortality in ‘this 
resource-poor setting’ (p. 301). 
 
Finally, and perhaps most relevant to the current research, is the study conducted by 
Richter (2015) which investigated overdose management among a sample of opiate users in 
Sweden.  The study involved qualitative interviews with 35 heroin users who had witnessed 
someone else’s overdose. Participants reported sympathy with and understanding for 
overdose victims and they generally displayed positive attitudes towards helping them.  
Nevertheless, many barriers to effective overdose management were reported, which 
included: an inability to respond due to their own state of intoxication, emotional numbing 
which reduced empathy or led to the situation not being taken seriously, the inability to 
determine the difference between an overdose and a heroin high, uncertainty about 
whether an overdose was a suicide attempt or an accident, and a reluctance to intervene 
and ‘spoil the high’ of another user.  
 
Calling for an ambulance was often found to be ‘a last resort’ once other methods (often 
including folk methods such as slapping victims and using ice or water) had been tried and 
had failed (p.96). Particular concerns were expressed about the risks of calling the 
emergency services and the potential of being accused of ‘involuntary manslaughter’ or 
homicide.  Interestingly, in some cases the witnesses determined whether the victim could 
be saved or not and those declared ‘beyond saving’ were left without assistance (p.96).  In 
conclusion, the authors recommend that simpler response techniques such as intranasal 
naloxone programmes be introduced to help speed up responses particularly among 
witnesses who are high and finding it difficult to respond.  In addition, the authors argue for 
more up-front communication among using peers so that intent (of suicide) is clear and for 
overdose prevention measures to address the fear of the police attending overdose events 
when emergency calls are made.  
 
 
Summary 
 
Overdose management has been an under-explored issue in the UK, particularly within the 
last 10 years. It is notable that the most recent UK publication is based on data collected 
nearly 20 years ago and that the most recent UK research is nearly 10 years old. There is 
evidently a need to investigate contemporary overdose events to examine whether the 
same messages remain relevant today or whether new issues need to be addressed. This is 
particularly important given the recent increase in drug-related deaths in Wales and across 
the UK (and the world). Our review of relevant research in other countries including the US, 
China and Sweden, has demonstrated that witnesses are often willing and able to respond 
to overdose events but many barriers remain that reduce the speed and efficiency of their 
responses. The question that remains to be answered is whether these findings reflect the 
UK situation and hence whether the recommendations made in these papers are 
appropriate for the UK context.  
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7. Methods 
 
The research was funded by USW (in collaboration with WG) and ethical approval for the 
study was granted by the USW Faculty of Business and Society’s Research Committee and, 
for the prison interviews, by the NOMS National Research Committee (see Appendix for 
further details).   
 
The research employed a cross-sectional design in which participants were questioned at a 
point in time about their direct and indirect experiences of opiate overdose.  The strategy 
adopted was largely qualitative although some quantitative data were also collected (e.g. 
number of times overdosed or witnessed an overdose and the number of times naloxone 
was used). The focus on qualitative data collection enabled us to gather detailed narrative 
accounts of events personally experienced or witnessed by participants (Bryman 2016).  
 
To gather this in-depth data, semi-structured interviews were conducted with eligible 
participants recruited from statutory and third sector drug treatment providers operating 
across South Wales and from two Welsh prisons. Staff members working within the 
agencies and prisons were instrumental in identifying eligible participants for us and in 
providing us with a safe place in which to conduct the interviews.  We are grateful to them 
for their assistance with this.  Fifty-five participants were recruited to the study - roughly 
half were recruited from community organisations (n=29) and half from the prisons (n=26). 
Eligibility was based primarily on whether the person was (or had recently been) and opiate 
user and whether they had personally experienced or witnessed an overdose event10.  
 
Participation in the research was voluntary and all participants were given details (verbally 
and in writing) about the nature and purpose of the research and what their participation in 
it would involve prior to taking part.  All participants were asked to sign a consent form to 
indicate their agreement to participate.  Recalling and reliving overdose events can be 
traumatic for victims and witnesses and we therefore took great care before, during and 
after the interviews to protect the well-being of our participants.  In some cases this 
involved stopping interviews, moving on to different topics, avoiding certain topics and 
referring participants to their key workers if they appeared upset at any point. From the 
outset, participants were advised that they could stop the interview at any point and 
withdraw from the research altogether if they wished.  Further details about the ethical 
issues involved in the research can be found in the Appendix.  
 
The interviews were digitally recorded (with the consent of participants) and lasted, on 
average for 22 minutes (ranging from 10 to 60 minutes). The interviews were conducted by 
the two researchers (roughly half each, 29 by one and 26 by the other). Audio recordings 
were deleted once they had been professionally and securely transcribed by Voicescript Ltd.  
The written transcripts were printed out and both researchers read through them 
independently.  Key themes were highlighted and discussed resulting in a set of key themes 
                                                             
10 Previous studies have used different definitions of an overdose.  Some researchers have defined overdoses to include 
events that required medical treatment while others have been less restrictive.  In our study, we made the decision not to 
include a definition as we were keen to avoid confusing our participants with a technical definition.  Furthermore, we had 
found in our previous research that opiate users had a good understanding of what the term meant.  This finding was 
supported by the current research which included a question on definitions as part of the interview.  Our participants 
routinely defined an overdose as an event during which an opiate user lost consciousness and was, for a period of time, not 
rousable.  
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that guided the computerised data analysis undertaken within NVivo. The computerised 
analysis was done manually using the coding tool and also with the help of coding queries 
(e.g. to search for particular words and combinations of words). Parent, child and sibling 
nodes were developed and used to store coded text (i.e. relevant quotations) that could be 
used as evidence to support our conclusions.  Before we present the results of this analysis, 
we will first give an overview of the characteristics of our sample. The main aim is to 
demonstrate that our sample was a credible one that could reliably comment on overdose 
events and help us to achieve our research aims.  
 
 
Sample characteristics 
 
The majority of participants were male (82%) and most were White British (93%) (see Table 
2). The average age was 34 (ranging from 18-54, SD 7.5 years). The demographic profile of 
the sample is therefore not dissimilar to that of all clients commencing treatment in Wales 
(Welsh Government 2016b).  
 
All participants had used heroin at some point in their lives and more than half (58%) listed 
heroin as their current primary drug (either alone or in combination with other drugs).  The 
majority of participants (95%) had a history of injecting and most had a history of previous 
treatment (93%). Of the 39 participants who reported that they were currently receiving 
treatment, all but one was receiving opiate substitute medication. More than three-quarters 
of the sample had served a term of imprisonment at some point in their lives and nearly half 
(47%, n=26) were in prison at the time of the interview.  
 
Table 2  Characteristics of the interview sample 
 
Characteristic N % 
Male 45 82% 
Female 10 18% 
   
White British 51 93% 
Other 4 7% 
   
Mean age 34  18-54; SD = 7.5 years 
   
Ever used heroin 55 100% 
   
Primary drug heroin 32 58% 
   
Ever injected 52 95% 
Ever had treatment 51 93% 
Currently in treatment 39 71% 
Currently substitute 38 69% 
   
Ever been in prison 43 78% 
Currently in prison 26 47% 
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As part of the interview, questions were asked about participants’ awareness and 
experience of Take Home Naloxone as well as questions about any witnessed or 
experienced overdoses (see Table 3).  More than three-quarters (78%) of the sample had 
received THN training and nearly two-thirds had been given a kit (including one untrained 
person who was given a kit by a friend). A little under one-third of participants had used a 
THN kit and 11% had used more than one kit. Overdose experiences were common among 
respondents with 80% reporting at least one overdose in their lifetime and 65% reporting 
multiple overdoses11. The majority (93%) of participants had witnessed an overdose event 
and more than one-third (35%, n=19) had witnessed a fatal overdose.   
 
Table 3  THN training and overdose events 
  
Variable N % 
THN training 43 78% 
Ever had a THN kit 36 65% 
Ever used THN kit 17 31% 
Used THN kit multiple times  6 11% 
Currently got a THN kit 20 36% 
   
OD ever 44 80% 
Multiple OD 36 65% 
   
Witnessed OD 51 93% 
Witnessed fatality 19 35% 
 
 
The primary purpose of the interviews was to obtain narrative accounts of overdose events 
that had been witnessed or experienced by the participants.  Fifty participants provided 
accounts of witnessed events and 43 provided accounts of their own personal overdose 
events.  Some participants provided accounts of more than one event while others focused 
on just one event.  In total, we obtained accounts of 107 unique overdose events from our 
sample of 55 participants.    
                                                             
11
 Calculating the average number of overdoses was not possible because participants were often quite vague about how 
many they had experienced. When probed, participants were unsure of how many they had experienced and preferred to 
give ranges rather than precise figures. For example: “10-20”, “5+”, “3 or 4”. The difficulty of recognising one’s own 
overdose and knowing what happened during that event is a limitation to the study which is addressed later in the report.  
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8. Results 
 
In this section we present the results of our analysis of the 107 accounts focusing on one 
specific topic - the management of overdose events.  Our aim is to establish how in practice 
opiate users respond to overdose events and to consider the implications of this for THN 
training and harm reduction practices more generally.  The results are structured around the 
four key issues that emerged from the analysis, namely: (1) recognising an overdose, (2) first 
responses, (3) use of folk methods, and (4) use of THN.   
 
1. Recognising an overdose 
 
It was clear from the accounts provided that recognising an overdose was not always 
straightforward. One particular problem was that many overdoses had occurred out of sight 
of potential witnesses. This was usually because the victim had gone somewhere private to 
inject, which meant that their overdose was not responded to or managed as quickly as it 
could have been had a witness been present. Many of our participants described, often in 
vivid terms, how by ‘luck’ or ‘chance’ they came across someone overdosing in another 
room. 
 
… he’d bought some and went upstairs and done it and no one thought to go up and 
check on him or anything until it was too late. When we’d found him, then we did 
realise about it then, rigor mortis had set in and everything as well so there was no 
point with resuscitation. (42) 
 
He was in the living room.  Me and my partner was in the kitchen.  His partner was in 
the kitchen with us, he was on his own in the living room. …Because we was arguing , 
his partner … turned round and walked into the living room. Then she come running 
back going “He’s gone. He’s gone over, he’s gone over”.  And then I ran into the living 
room and he’s just on the settee like. You could see he was grey, do you know what I 
mean, straight away within 10 minutes, 5 minutes of him doing it. (17) 
  
Several participants described events where the victim had injected privately in the 
bathroom. On some occasions the victims overdosed close to the door which blocked access 
to the people outside and delayed them from providing assistance.  
 
He went into the bathroom to inject because he was injecting in his groin and the 
other two injected into our arms. But, then he was taking a long time in the toilet, so 
it was like “Oi, where are you” and then knocking on the door. I tried to open the 
door and he was behind the door. (28) 
 
They’d locked themselves in and God knows how I managed to unlock it from the 
outside because I’ve tried recently to see how I did it but I must have had a panic and 
managed to do it.  … I managed to call the ambulance and sort of bring them round a 
bit.  But if I couldn’t unlock that door God knows what could have happened to him 
like. (34)  
 
… she actually left the room where they all were and went to use in the bathroom.  It 
was a good job that her daughter thought, “where’s my Mum, she hasn’t come 
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back.”  She went to the toilet, couldn’t open the door; the door was jammed by her 
Mum. (41) 
 
Even when witnesses were physically present in the same room, they were often not 
present mentally. This was usually because the witnesses were intoxicated themselves and 
were not capable of noticing that an overdose was taking place.  This again, delayed or 
prevented appropriate responses from taking place.   
 
Everybody in the party thought he was just asleep. We’d been up for days.  We 
thought he was just like, but he was dead. … Well, I’d been taking MCat, so I was on 
the roof.  I didn’t care about anything.  I wasn’t really paying any attention to 
anything. (48)  
  
Sometimes, both physical and mental presence was not enough to trigger a response.  Some 
witnesses did not realise the victim was overdosing simply because they were not paying 
attention.   
 
You’d be surprised how easy it is for somebody to go over and you not even notice. 
(55)  
 
I wasn’t taking much notice, to be honest (23) 
 
On other occasions, however, the witnesses did not know that an overdose was occurring 
because they were not prepared to check whether someone was overdosing or ‘gouching 
out’12.   
 
Well, it’s a fine line isn’t it, and short of shaking a person every couple of minutes 
saying are you gouching or are you not able to respond, which nobody wants … 
When you’ve taken your drugs, you don’t want someone shaking you every two 
minutes to make sure you are still compos mentis. (30)  
  
This reluctance to ruin someone’s ‘buzz’ was also reported by Richter (2015) in his study of 
overdose events among heroin users in Sweden.  Encouragingly, however, not all of our 
participants felt this way.  One described how she would routinely check on her fellow users 
by shaking them and how she was not at all concerned about spoiling their buzz if it meant 
saving their lives. 
 
 So now I don’t care if I’m spoiling somebody’s buzz to be honest.  I’d rather know – 
you’re in my company - so I’d rather know you’re all right than, “Oh see you later, ta-
ra,” give them a kick and they’re not moving and then find out the next day, “Oh so 
and so OD-d last night.  So and so passed away.”  Just by me shaking them would 
have brought them round.  So what if I’m spoiling your buzz – tough. 
 
This tends to suggest that the culture of not checking is not so ingrained and pervasive that 
there is not scope to change it.  
                                                             
12
 The term gouching is commonly used by heroin users to describe the ‘nod’ or drowsy, dream-like state that 
users experience after consuming heroin (see DAN 24/7.org.uk). 
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Key messages 
It is clear from the accounts provided by our participants that problems in recognising 
overdoses often delayed (and sometimes prevented) life-saving actions from taking place.  
In some cases the delays meant that it was too late to save the victim’s life.  It is therefore 
important that lessons are learned from these accounts and that strategies are developed to 
help ensure that overdoses are recognised as quickly as possible.  One way of doing this 
might be to adjust the guidance given to users so that the emphasis on ‘not using alone’ is 
shifted to ‘using in sight’ of others.   
 
If users can be encouraged to use in sight of others, they could be encouraged to use in sight 
of someone who is capable of recognising and responding to an overdose (i.e. someone who 
is not too intoxicated him/herself). One way of doing this might be to encourage staggered 
use whereby one person is the ‘designated smoker’ who smokes a small amount of the drug 
(to take the edge off their withdrawal) whilst others inject. This could help to ensure that at 
least one person in the group remains capable of calling for an ambulance and/or 
administering naloxone. While this might be an ambitious goal given the nature of opiate 
use and the compulsion to inject among users, Richert (2015) has suggested that it may 
work among certain groups such as couples or people with close relationships. Indeed, one 
of our participants described how she and her partner would routinely check on each other 
when using: 
 
 Well we both make sure that we – we both keep an eye on each other when we 
use.  I always call in to him.  If he goes into the bathroom to use I always call into 
him every whatever, however long, to make sure he’s still responding back. (34) 
 
However, those users who do persist in using alone might be encouraged to let someone 
know where they are going, to leave the door of that room unlocked and, if possible, to use 
the drug away from the door so that the entrance is not blocked if they overdose and 
collapse.  The importance of checking on fellow users could also be emphasised. Ruining the 
buzz is a risk worth taking when lives are at stake.  
 
Finally, drug consumption rooms in which users are able to inject drugs safely in the 
presence of capable and willing witnesses would address all of the issues highlighted in this 
section. Recent reports indicate that there are more than 90 drug consumption facilities 
operating across 10 countries across the world, including six European countries (Australian 
Drug Law Foundation 2014, EMCDDA 2015). Interestingly, figures from the Sydney facility 
indicate that staff members have responded to more than 5,000 overdose events on site 
and there have been no fatalities (Australian Drug Law Foundation 2014).   
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2. First responses 
 
Once an overdose has been identified the opportunity to respond arises. In theory, the first 
response should be to call 999. In practice, however, the first responses reported by our 
participants were usually shock, panic, screaming and shouting.  All of these responses 
served to delay more appropriate responses from taking place.  
 
… everyone was screaming and shouting. (46)  
 
I just stood there like a shivering wreck sort of thing. (55)  
  
In many of the accounts provided, participants reported that ambulances had been called.  
In some cases this was done promptly after the overdose had been identified. In fact, in one 
case it was called a little too promptly (e.g. when someone was “just gouched” and not in an 
overdose state). However, this was rare and in some cases the reverse was true, and delays 
were evident sometimes with fatal consequences. Reasons for delay were varied and 
included: conflict at the scene, other responses taking precedence, moving the victim to a 
different location, and hiding drugs.  The following quotation is a good example of a case 
where conflict at the scene resulted in a delay in calling for ambulance.  
 
I said, ring the ambulance.  No, no, no.  I said, ring the ambulance.  Nobody would 
ring the ambulance.  So I took the phone off one of the girls who was there … and 
said ‘f*** off’, rang the ambulance. … She was alive until she nearly got to the 
hospital and then ended up it killed her. (48)  
  
In a small number of cases it was evident that an ambulance had not been called.  Two 
interviewees explained that this was because the victim would not have wanted them to 
because involving the authorities might have a negative impact on their lives (e.g. they 
would have lost their room in a hostel where drug use was not permitted).  Interestingly, in 
one case the decision not to call 999 was described almost as if it were a life-saving action. 
The participant explained that she was concerned that the victim might leave the scene and 
overdose again somewhere else out of sight of any witnesses.   
 
I’d rather him stay there to make sure he’s ok instead of him wandering off because 
we’d called the ambulance. (7)  
  
It was encouraging to note that witnesses, on the whole, cared about the victims and while 
they may not have responded according to the book (often for fear of the consequences for 
themselves), they usually did something to try to save the victims’ lives. The following 
quotation illustrates this very well. 
 
… put him into the recovery position then and cleared his airways and then he started 
breathing. But that scared me because I stayed up all night with him because he was 
going back under after I’d brought him round. … I didn’t want to phone the 
ambulance then because my girlfriend was pregnant.  Social Services would have 
been involved straight away.  So that was a very close one that was. (46)  
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Even in cases where the relationship between witness and victim was not a close one, 
witnesses still did things to help even if they did then leave the scene.   
 
I just leave because it’s only a drug relationship.  So it’s like yeah all right, I’ve got my 
drugs, it’s a shame you’re going over.  I’ll do my best to help you but I’m off because 
drug users don’t want police involved and it’s the way it is. (16)  
  
In line with previous research, it was a rare event (only one in fact) where the witness did 
nothing to help.   
 
I’ve seen a young girl go over … I just left.  I shouldn’t.  That was a terrible thing to 
do, but I just panicked.  I’d a pocketful of drugs, so I’d gone. (48)   
  
It was more common for participants to describe how ‘others’ would run off and leave 
victims, or throw victims out onto the street, but how they were not like that.   
 
But some people leave them and run away, and that’s dangerous.  I would never, 
never do that and I try to tell people don’t, it’s not fair.  Even call the ambulance, 
don’t just leave them lying there. (2)  
 
I’ve been in situations where people have gone over and the person whose flat it is, is 
‘right, chuck them outside. Phone an ambulance’, and it’s like, well no,  that’s my 
mate.  Do you know what I mean. I wouldn’t do that to a dog, never mind a person.  
It’s only been a handful of times it’s ever happened, but every time I’ve taken 
responsibility and told them ‘no chance, I’m phoning an ambulance. (28) 
 
It should be acknowledged, however, that there may be alternative explanations for these 
findings. For example, it is possible that our sample was biased and excluded people who 
run off and leave overdose victims. It is also possible that our participants did not wish to 
disclose to us that they had left the scene of an overdose potentially leaving someone to 
die.  
 
 
Key messages 
 
It was evident from the accounts provided that participants’ first response to an overdose 
was usually panic and this served only to delay appropriate responses from taking place.  
One way of addressing this issue might be to try to prepare potential witnesses for the 
inevitable panic as part of any overdose management training given.  The benefits of calling 
999 and of passing on the enormous responsibility of saving someone’s life to medical 
professionals could also be highlighted.   
 
It was also clear from the accounts that witnesses usually helped others.  This culture of 
supportive action and pro-social behaviour could be more widely promoted to show users 
that this is standard practice.  The sense of heroism and satisfaction and increased self-
esteem having saved a life could also be promoted (see also Wagner et al 2014).  Fear of the 
authorities is clearly extremely powerful and in many cases this delayed appropriate 
responses (i.e. calling 999) from taking place.  In Wales, the Police do not routinely attend 
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overdose events unless a flag has been placed on the address to highlight potential dangers 
to paramedics.  Wider publicity of this might go some way towards ameliorating concerns 
about police presence. Richert (2015) suggested that exemption laws (such as the Good 
Samaritan 911 laws in the US) could be introduced to ensure that heroin users who seek 
medical assistance at overdose events are ‘not themselves liable to be prosecuted for their 
use or possession of illicit drugs’. Richert (2015) also suggests that decriminalising the use of 
illicit drugs and possession of illicit drugs for personal use would have a similar effect.  
 
 
3. Use of ‘folk methods’ 
 
The use of ‘folk’ methods (or ‘home remedies’) as a means of managing overdose events has 
a long history. Folk methods are inappropriate actions taken by witnesses in the mistaken 
belief that they will help reverse an opiate overdose. Examples include: slapping victims, 
inflicting pain, throwing water on them, applying ice, walking them around, and injecting 
them with stimulants or salt water (Wagner et al 2014, Richert 2015). THN training 
programmes usually discuss these ‘myths’ and emphasise the need to avoid using such 
methods. Nevertheless, in our study, witnesses (and victims) reported use of these methods 
almost as a matter of routine.  This was not because the witnesses were unsure someone 
was overdosing and they were checking, rather it was because they knew they were and 
they wanted to help (either instead of or before calling for an ambulance, or while waiting 
for an ambulance to arrive). 
  
While none of our participants described injecting victims with stimulants or salt water, 
many described walking victims around, using water and slapping them.  On some occasions 
a combination of these actions were taken.  
 
Then I just got him up and just kept on pacing him, both of us holding him up, pacing 
him, waiting for the ambulance. (28) 
 
Yeah, I blacked out and they said I fell to my knees and it was like I had been shot or 
something.  I just fell to my knees and then onto my face.  Them I came round and 
they were throwing water all over me. (9) 
 
Basically we tried waking him up, and one of the boys said chuck cold water on him 
that will wake him up. (50) 
 
I was slapping his face and all like trying to make himself come round and then I sort 
of was trying to hold him to come into the sitting room, like pick him up, but he was a 
bit of a pain to be honest with you. (34) 
 
… I just remember waking up soaking wet.  But they did all the wrong things to me 
anyway, the way they were going on.  They were slapping me, the usual stuff people 
think brings you round, which it doesn’t, does it?  Throwing water in my face, 
slapping me, trying to walk me around. (46) 
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What was evident from the accounts was that the folk methods, or home remedies, had 
apparently worked in the past and were therefore seen as viable responses.  Recovery and 
survival were associated with use of these methods which resulted in their continued use. 
This point is illustrated well in the following quotation from one participant who describes 
how he had used folk methods ‘successfully’ on multiple occasions but when they were not 
used the victim, his Uncle, died. 
 
I would throw cold water and slap them and bring them along, and pick them up and 
walk them, but they say don’t do that.  But, I said, well I have brought tons of people 
around doing that whereas my Uncle died but I didn’t try bringing him around. (53)  
   
 
Key messages  
 
The accounts provided indicate that the use of folk methods is commonplace and this is in 
spite of efforts to dispel the myths as part of THN training programmes. The main problem 
appears to be that folk methods have become associated with recovery and survival and this 
has served to reinforce beliefs that they are appropriate and helpful.  Evidently, there is a 
need to educate potential witnesses about the concept of natural recovery and a need to 
explain that the relationship between recovery and use of folk methods is coincidental 
rather than causal. It is likely that the person would have recovered anyway regardless of 
the folk method(s) used. In fact, the person may have recovered more quickly if folk 
methods had not been used.  Walking someone around, for example, may waste time and 
also result in a fall (Scottish Drugs Forum 2013). Furthermore, as the heartbeat increases 
with the exercise of walking, the drugs may be absorbed into the bloodstream more quickly 
resulting in a more rapid overdose (Exchange Supplies 2009).   
 
 
4. Use of Take Home Naloxone 
 
Most of the participants in our sample were aware of THN and many had undergone the 
training and been given kits.  Some had actually administered THN during the course of 
overdose events.  However, in some cases interviewees described not carrying their kit and 
how they had to leave the overdose scene to go home and get it.  This inevitably delayed 
the administration of naloxone, which in the example below, had fatal consequences.  
 
It took me about five, 10 minutes then, to ride home on my bike, get the naloxone, 
come back, and administer it.  And it was just too late, I think; he was already dead 
by then. (41)  
  
The need for more than one dose (which was the formulation provided in Wales at the time 
the interviews were conducted) was also described by some interviewees. However, some 
participants described events where the victim seemed unaware of the need for more than 
one dose as they did not understand that there was a possibility of overdosing again after 
the naloxone had worn off (approximately 20 minutes).  In the example below, the victim 
described wanting to cancel the ambulance, which had he overdosed again and no more 
naloxone was available, could have had fatal consequences.  
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So he went back in and administered the Naloxone on me, banged it in my leg I think 
it was, and I came around.  Fifteen/twenty seconds, I came around.  But before he did 
that, he phoned the ambulance, and I was like, "Cancel it.  Cancel it."  Obviously I was 
embarrassed, you know? (5)  
   
A further cause for concern was the finding that prisoners reported having been trained 
whilst inside prison but had not been provided with a kit on release.   
 
No.  # Prison asked me if I wanted a kit and they said it would be in reception for 
when I went home.  I never received it. (46)   
 
I was meant to have a kit the day I got out but it never happened for some reason. 
(48) 
 
Others reported not wanting a kit because they were not planning to be around drug users 
in the future and there was therefore no need.   
 
 I think they say that you can do it so they give it you to release with but to be honest 
I’m not planning on going back around the drug users.  I’m going back to my family 
and I don’t even want to be thinking about carrying a Naloxone kit with me because 
I don’t even want to be thinking about going to those places where the drug users 
are, so I just want to try and cut it all out and just stop it completely and stay away 
from it all.  If I was actively going out to carry on using and carry on doing what I 
was doing then yeah I probably would take one, but that’s not my plan. (43) 
 
I won’t need one; I’ve got no plans on going back to them circles. (47) 
 
I’ve got myself clean and I’ve sorted my head out.  I think I’ve sorted my head out 
anyway.  I don’t want it anymore.  I’m tired of it.  I’ve lost everything in my life, 
everything that ever mattered to me because of drugs. (48) 
 
One person explained that he did not want a kit because he always used alone.  This 
participant believed that there was no point in having a kit because he would not be able to 
administer it to himself.  
I have not felt the need for it because when I've used I've used solo. (21) 
 
Some participants expressed concern about the message that wanting a THN kit gave to 
treatment providers. This could be a particular concern for those on court orders and 
undergoing drug testing.   
  
Interestingly, some witnesses who had been trained and had been given a THN kit described 
a reluctance to use them. In the quotation below, the participant describes a fear of doing 
something wrong and the need for follow-up training to help improve confidence. 
 
I just talk to them.  I’ve always talked.  Like when my friend OD-d in the bathroom 
and with my partner I just try talking to them and try and bring them round.  I know 
they say you shouldn’t try standing them up and walking them around but you do, 
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don’t you, naturally I suppose just to see if they can do it, so that’s what I’d do.  I 
don’t know, I’ve got a Naloxone set, but I’ll be honest with you, I wouldn’t know how 
to administer Naloxone even though I’ve done the training.  I think it’s because I’d be 
too panicked that I’d get it wrong or I’d be too panicked in the moment that I just 
wouldn’t be able to do it.  I’ve got the set but I think I’d better do the training again 
to be honest with you. (34)  
 
The need for follow-up training has also been highlighted by Public Health Wales (2015) who 
reported that more than three-quarters of service users who had received THN training had 
not received any follow-up training (77%, 3818/4939).  
 
 
Key messages 
 
THN is an important way in which overdoses can be reversed and lives can be saved.  The 
accounts provided by our participants highlighted the importance of encouraging users to 
carry THN kits at all times. If a kit is left at home, valuable time can be lost and lives can be 
lost as a result.  The accounts also emphasised the importance of providing multiple doses 
of naloxone. Sometimes, one dose is not enough and without additional doses victims may 
be at risk of death. Encouragingly, Welsh Government has already addressed this issue and 
Prenoxad (which contains five doses) is now the preferred formulation distributed across 
Wales. Ensuring that all trained prisoners receive kits on release is of paramount importance 
given that the period immediately following release is a known risk period for overdose 
(Merrall et al 2010).  THN must be made easily available for all people at risk (even those on 
court orders).   
 
It was clear from the interviews that some people did not want to be given THN.  For some 
people carrying THN conflicted with their goal of abstinence and plans for the future.  
Others were concerned that asking for THN would highlight the fact that they were still 
using heroin to treatment providers. This may be a particular concern for people on court 
orders.  One way of addressing these problems might be to shift the emphasis away from 
personal need to the potential benefits to others. For example, users might highlight the 
fact that they know heroin users and would like a kit in case one of their friends overdoses. 
Similarly, for those who did not plan to be around heroin users, providers might encourage 
people to carry a kit just in case someone who knew them asked to use it. Treatment 
providers could also be encouraged to offer training routinely to all clients thereby avoiding 
the need for a client to request it.  
 
Q So what would get you trained? 
A Well if they offered me it here I’d say yeah straightaway like.  I haven’t asked 
about it to be honest with you but if they turn around to everyone and said, 
“Do you want it,” I would say yeah straightaway like. 
Q So really people asking you rather than you have to ask them to do it? 
A Yeah.  Because it’s not the first thing that pops up on your mind like. (7) 
 
When you go to needle exchanges and say you see your drug worker or something, 
they hardly ever mention it and the majority of the time you bring it up.  (11) 
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Finally, overdose management training needs to be more widely available, perhaps as part 
of generic NSP services.  This would help to ensure that those who already have kits, those 
who are reluctant to get a kit and those who got hold of kits without undergoing training, 
are educated in how best to manage overdose events and potentially save lives.  Ideally, this 
education should be continuous and not a one-off. As several of our interviewees explained:  
 
All you can do is educate people and hope they learn from it. (12)  
 
The more you say it, the more you’re going to take it in and it’s kind of stuck with 
you. (34) 
 
“Keep drilling awareness … awareness, awareness, awareness …” (36) 
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9. Conclusions 
 
In this report we have presented findings from a qualitative study of overdose experiences 
(both direct and indirect) among a sample of opiate users in South Wales.  When drawing 
conclusions, however, it is important to recognise the limitations of the research.  Perhaps 
most importantly is the fact that this is a qualitative study based on a sample of 55 opiate 
users. Drawing inferences about the prevalence of phenomena observed beyond the sample 
must therefore be done with caution (Neale, Miller and West 2014, p. 175).   
 
Like most cross-sectional studies that rely on self-report surveys of substance misusers, the 
research is also thwarted by the issues of accuracy of recall and honesty (Neale and 
Robertson, 2005). Accuracy of recall is particularly problematic in an overdose situation 
where respondents are unconscious and unaware of what is occurring or, in the case of 
witnesses, intoxicated or in a state of shock (Bennett and Higgins, 1999). Nevertheless, in 
spite these weaknesses, self-report is widely used in research on drug users and there is 
evidence to suggest that it can produce reliable results (Dietz et al., 2005). There is also no 
real alternative to a self-report survey given the hidden nature of non-fatal opiate overdose.  
 
The decision not to include a definition of an overdose in the survey might also be seen as a 
limitation given that respondents might define overdoses in different ways. Our decision not 
to provide a definition was based on previous research which demonstrated that opiate 
users have a broad understanding of what an overdose involves.  We were also keen to 
investigate how our participants defined an overdose and supplying a definition to them 
would have confounded this investigation.  Finally, the study is limited by the fact that the 
sample is biased in favour of participants who were willing to participate. It is possible that 
unwilling participants experienced overdose events in different ways. Generalising the 
findings beyond the current sample therefore needs to be done with caution.  
 
Accepting these limitations, the study provides new evidence on the characteristics of 
overdose events and the management of them among opiate users in Wales.  The results 
confirm (and extend) those found in other countries (see Wagner et al 2014, Richter 2015) 
and could therefore help to shape the future of overdose management in Wales and 
possibly further afield.  
  
Perhaps the most important finding to emerge from this research is the need to provide 
overdose management training more widely rather than just as part of THN training.  Not 
everyone who is a potential witness wants THN training and people sometimes slip through 
the net and do not get given the option.  It is important that the opportunity of educating 
them in how to manage overdose events is not lost.  One way of doing this might be to 
incorporate overdose management techniques within the generic harm reduction advice 
provided within NSP services, which has traditionally focused on preventing overdoses 
rather than responding to them. 
 
The need for wider provision of THN kits also emerged as a key issue. Some participants 
reported a reluctance to obtain a kit because this conflicted with their plans for abstinence. 
Shifting the emphasis away from personal need to the potential benefits for others may be 
one way of ensuring that kits are more widely distributed. Treatment providers have an 
important role to play here and thought might be given to encouraging providers to offer 
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training routinely to all clients thereby removing the onus of requesting training and kits 
from clients. 
 
Richter (2015) recommended more up-front communication and discussion amongst using 
peers in relation to motives for overdose. We did not investigate motives for overdose 
within our research (and none of our participants mentioned it).  Nevertheless, we support 
Richter’s recommendation for greater communication amongst drug-using peers in relation 
to a range of other issues including: use of appropriate responses, use of inappropriate 
responses, the dangers of private ‘out of sight’ use, the fact that police did not turn up when 
999 was called, the sense of heroism felt upon saving a life (see Wagner et al 2014) and 
debriefing in the aftermath of an overdose event. This latter point is particularly important 
given that some of our participants knew very little about what had happened to them 
during an overdose event meaning that lessons could not be learned.  In fact, in some cases 
the participants did not even know that they had overdosed and only learned of this by 
chance. 
 
About a week later one of the boys said to me in DIP, ‘what were you doing in an 
ambulance last week outside here?’  I said ‘I wasn’t?’  He said ‘you were’.  I said ‘I 
wasn’t’.  He said ‘trust me, you were in an ambulance.  And, I asked the staff and 
they said, ‘yeah you overdosed outside’.  So, I couldn’t even remember because I was 
taking more drugs again after what had happened. … No recollection of it.  … 
because it happened about three or four times in a matter of two or three months, 
my Mum took a photo of me in the hospital bed to shock me into realisation. (50) 
 
Another obstacle that affected responses to overdose events was fear of the consequences 
of involving the authorities. This fear has been widely reported in the literature and clearly 
remains a concern today.  It seems that users are still fearful of the police turning up even 
though they are no longer routinely requested when a 999 call is made. One solution might 
be to advertise more widely the role of the police in overdose events. Alternatively, if 
exemption from prosecution is assured in the event that an ambulance is called then it is 
likely that ambulances will be called more often and more quickly, which may help to save 
lives and reverse the recent upward trend in drug-related deaths in Wales.    
 
Our final point is an encouraging one.  We were impressed by our participants and their 
willingness to help others during overdose events. Only one respondent admitted that they 
had left the scene of an overdose having done nothing to help. By contrast, other 
respondents described going to great efforts to keep someone alive.  Given that opiate 
users are willing to help, it is important that they are given the right tools at the right time 
with the right kind of advice, in order to reduce as much harm and save as many lives as 
possible.  
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10. Recommendations 
 
Our research has highlighted a number of ways in which the management of overdose 
events might be improved. We have therefore used this information to develop a set of 
recommendations that might be useful for policy makers and practitioners. The 
recommendations are presented below in four groups corresponding with the four key 
areas of our analysis.  
 
 
Recognising an overdose: 
 
 To adjust current overdose management advice so that the emphasis on ‘not using 
alone’ is shifted to ‘using in sight’ of others.   
 To encourage users to use only when in sight of someone capable of recognising and 
responding to an overdose. 
 To promote among groups of users, the idea of a ‘designated smoker’ who smokes a 
small amount of the drug, to take the edge off their withdrawal, while others inject. 
 To encourage users to check on fellow users to ensure that they are not overdosing.  
 To encourage people who persist in using out of sight to: let someone know where they 
are going, to leave the door of that room unlocked and, if possible, to use the drug away 
from the door so that the entrance is not blocked if they overdose and collapse.   
 To develop harm reduction facilities where users can inject safely in the presence of 
medical professionals (i.e. capable and willing witnesses) without fear of prosecution.  
 
 
First responses: 
 
 To ensure that overdose management training raises awareness of the inevitable panic 
that will be experienced during an overdose event. 
 To emphasise during overdose management training that calling 999 will bring medical 
professionals to the scene who will relieve users of the enormous responsibility of saving 
a life.  
 To promote among users the culture of supportive action and pro-social behaviour that 
is so evident among witnesses of overdose events.  
 To promote the sense of heroism, satisfaction and increased self-esteem experienced by 
witnesses who have saved someone’s life.  
 To ameliorate concerns about potential arrest by more widely advertising the role of the 
police in overdose events.  
 To consider introducing exemption laws (such as the Good Samaritan 911 laws in the US) 
to ensure that those who seek medical assistance for others at overdose events are not 
themselves liable to be prosecuted for their use or possession of illicit drugs.  
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Use of folk methods: 
 
 To ensure that overdose management training educates potential witnesses about the 
concept of natural recovery and the coincidental (rather than causal) relationship 
between recovery and use of folk methods. 
 To continue to educate potential witnesses of overdose events about the inappropriate 
use (and dangers) of using folk methods.  
 
Take Home Naloxone: 
 
 To encourage users to carry kits whenever possible. 
 To continue to provide multiple doses of naloxone. 
 To ensure that all trained prisoners receive THN kits on release from prison. 
 To ensure that THN kits are accessible to everyone at risk (even those on court orders). 
 To encourage ownership of THN kits by shifting the emphasis away from personal need 
to the need of others. 
 To shift the emphasis from requesting a THN kit and training by clients to offering THN 
kits and training by providers. 
 To incorporate overdose management advice within the generic harm reduction advice 
provided within NSPs. 
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12. Appendix 
 
Ethics 
 
1. Informed consent 
 
The respondents need to have sufficient information about who we are, why we are 
conducting the research, and what we will do with the results in order to make an informed 
choice to consent. To this end, when recruiting participants from community settings (i.e. 
needle exchange schemes), we will provide them with a short statement containing 
information relevant to informed consent (e.g. a statement about who is commissioning the 
research, how the results will be used, confidentiality of the respondents etc.).  
 
When recruiting participants from within the prisons, we will provide detailed information 
to prison staff and a summary statement will be uploaded onto the prison intranet.  The 
same summary will be included at the beginning of the on-line survey. 
 
A summary of the statement will also be repeated at the start of all interviews. We will then 
advise participants that we are going to be discussing overdose events that they may have 
experienced or witnessed and that this might be distressing for them. We will ask them if 
they are happy to proceed and feel up to talking about it. This process will help to ensure 
that participants know what to expect from the interview and are therefore fully informed.  
 
2. Confidentiality 
 
With the participants’ persmission the interviews will be digitally recorded and 
professionally (and securely) transcribed by Voicescript Ltd.  The recordings will be deleted 
from the recorder and computer as soon as they have been uploaded for transcription. 
Electronic copies of transcribed files will be stored on the principal researcher’s secure 
University hard drive.  Hard copies of transcribed files will be kept in a locked filing cabinet 
in the researcher’s locked office.   
 
At the start of each interview we will advise each participant that his or her identity will 
remain confidential unless he or she refers to an intent to harm him/herself or someone 
else. In such cases, the interview will be brought to a close and the information will be 
passed on immediately to the participant’s prison officer, drug worker or the drug agency 
that he or she was recruited from.  
 
 
3. Anonymity 
 
If community-based participants opt for a telephone interview this would require them 
leaving a contact number in a sealed envelope in the needle exchange. We are happy to 
accept pseudonyms or personal names; whichever the respondent prefers. The sealed 
envelopes will be stored securely within the needle exchange and collected by the 
researcher on a regular (weekly) basis. Upon collection the cards will be stored securely in a 
locked cabinet in the principal researcher’s locked office.   
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Prisoners who complete the on-line survey will not be asked to provide any identifying 
information. The survey results will be downloaded and stored securely on the secure 
University hard drive. If prisoners are interested in taking part in an in-depth interview, they 
will need to let a prison officer know. The prison officer will then pass on the prisoners’ ID 
numbers to the researchers.  
 
At the start of all interviews, participants will be advised that quotations may be extracted 
from the interview and used in published reports. Participants will be reassured that the 
quotations will be anonymised and that their identity will be protected. 
 
 
4. Whether the respondent is harmed by the research  
 
The community-based interviews will take place either on the telephone or in a drug agency 
which would provide support and advice if the respondent was disturbed by the experience. 
We will also provide information on where to obtain help relating to drug misuse or 
overdose (including information on the naloxone [overdose-related] scheme).  
 
If during the course of the interview participants become distressed, they will be advised to 
contact their drug worker or the drug agency that they were recruited from. They will be 
asked if they are happy to do this themselves or if they would like the interviewer to do it on 
their behalf.  We will also provide them with the number of the Samaritans (08457 90 90 
90). 
 
At the end of all community-based interviews we will thank participants for their time and 
advise them that they should contact their drug workers or drug agency if they have any 
problems that they would like to discuss. We will also provide them with the telephone 
number of the Samaritans (08457 90 90 90).  
 
The prison-based interviews will take place in the prison visits block, which is supervised by 
prison staff. If participants become distressed during the interview, they will be advised to 
contact their prison drug worker or a prison officer.  They will be asked if they are happy to 
do this themselves or if they would like the interviewer to do it on their behalf.   
 
At the end of all prison-based interviews, we will thank participants for their time and advise 
them to contact their prison drug worker or a prison officer if they have any problems that 
they would like to discuss.  
 
 
5. Issues relating to personal safety of the researchers 
 
The community-based interviews will be conducted either face-to-face or over the 
telephone. If participants opt for a face-to-face interview, this will be conducted in a private 
room in a drug agency. In such cases, the interviewer will make sure that someone in the 
agency is aware that the interview is taking place and that other people are nearby.  
 
 36 
 
The prison-based interviews will be conducted face-to-face in the prison visits block. The 
interview will be conducted privately so that no one can hear the conversation, but prison 
staff will be able to observe the interview taking place.  
 
 
6. Issues relating to the effect of the survey on the person’s treatment experience 
 
Respondents recruited from community settings will be told by the drug worker that the 
research has nothing to do with them as individuals and is not connected with their support 
from the agency. Potential respondents will be asked if they are willing to take part in the 
research and their refusal will be accepted without question.  
 
Respondents recruited from prison settings will be under no obligation to participate in 
either the on-line survey or the interview.  They will be advised that their decision to 
participate or not to participate will not affect their treatment within the prison. 
 
 
 
